Search Results - "Pontes, J E"

Refine Results
  1. 1

    How healthy are clones and their progeny: 5 years of field experience by Panarace, M., Agüero, J.I., Garrote, M., Jauregui, G., Segovia, A., Cané, L., Gutiérrez, J., Marfil, M., Rigali, F., Pugliese, M., Young, S., Lagioia, J., Garnil, C., Forte Pontes, J.E., Ereno Junio, J.C., Mower, S., Medina, M.

    Published in Theriogenology (2007)
    “…There is considerable concern regarding the health of cloned cattle and their safety as a source of food. The objective was to summarize 5 years of commercial…”
    Get full text
    Journal Article
  2. 2

    The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients by Sakr, W A, Haas, G P, Cassin, B F, Pontes, J E, Crissman, J D

    Published in The Journal of urology (01-08-1993)
    “…The incidence of clinically detected prostate cancer is increasing with more frequent diagnosis in younger male patients. Whether this represents a genuine…”
    Get more information
    Journal Article
  3. 3

    Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy by Cher, M L, Bianco, Jr, F J, Lam, J S, Davis, L P, Grignon, D J, Sakr, W A, Banerjee, M, Pontes, J E, Wood, Jr, D P

    Published in The Journal of urology (01-10-1998)
    “…Bone scintigrams of patients with increasing serum prostate specific antigen (PSA) after radical prostatectomy are only rarely positive. We identify clinical…”
    Get more information
    Journal Article
  4. 4

    The Surgical Learning Curve for Prostate Cancer Control After Radical Prostatectomy by Vickers, Andrew J., Bianco, Fernando J., Serio, Angel M., Eastham, James A., Schrag, Deborah, Klein, Eric A., Reuther, Alwyn M., Kattan, Michael W., Pontes, J. Edson, Scardino, Peter T.

    “…Background The learning curve for surgery—i.e., improvement in surgical outcomes with increasing surgeon experience—remains primarily a theoretical concept;…”
    Get full text
    Journal Article
  5. 5

    Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade by F J Bianco, Jr, D C Gervasi, R Tiguert, D J Grignon, J E Pontes, J D Crissman, R Fridman, D P Wood, Jr

    Published in Clinical cancer research (01-12-1998)
    “…The matrix metalloproteinases (MMPs), in particular the gelatinases (MMP-2 and MMP-9) have been associated with tumor cell invasion and metastasis in many…”
    Get full text
    Journal Article
  6. 6

    Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival by JIMENEZ, R. E, GHEILER, E, OSKANIAN, P, TIGUERT, R, SAKR, W, WOOD, D. P, PONTES, J. E, GRIGNON, D. J

    Published in The American journal of surgical pathology (01-07-2000)
    “…Although grading is valuable prognostically in pTa and pT1 papillary urothelial carcinoma, it is unclear whether it provides any prognostic information when…”
    Get full text
    Journal Article
  7. 7

    High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer by GRIGNON, D. J, SAKR, W, TOTH, M, RAVERY, V, ANGULO, J, SHAMSA, F, PONTES, J. E, CRISSMAN, J. C, FRIDMAN, R

    Published in Cancer research (Chicago, Ill.) (01-04-1996)
    “…The matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases (TIMPs) have been associated with tumor invasion and metastasis in many…”
    Get full text
    Journal Article
  8. 8

    Outcome of palliative urinary diversion in the treatment of advanced malignancies by Shekarriz, Bijan, Shekarriz, Hodjat, Upadhyay, Jyoti, Banerjee, Mousumi, Becker, Herman, Edson Pontes, J., Wood, David P.

    Published in Cancer (15-02-1999)
    “…BACKGROUND It is unclear whether palliative endourologic or percutaneous urinary diversion in the treatment of advanced cancer provides significant improvement…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease by Powell, Isaac J, Banerjee, Mousumi, Novallo, Mary, Sakr, Wael, Grignon, David, Wood, David P, Pontes, J.Edson

    Published in Urology (Ridgewood, N.J.) (01-02-2000)
    “…Objectives. To determine whether outcome differences between African-American men (AAM) and white men with prostate cancer (PCa) will still be present if we…”
    Get full text
    Journal Article
  10. 10

    Lymph node size does not correlate with the presence of prostate cancer metastasis by Tiguert, Rabi, Gheiler, Edward L, Tefilli, Marcos V, Oskanian, Peter, Banerjee, Mousumi, Grignon, David J, Sakr, Wael, Pontes, J.Edson, Wood, David P

    Published in Urology (Ridgewood, N.J.) (01-02-1999)
    “…Objectives. To determine whether lymph node size is a surrogate marker for lymph node metastasis. Methods. We reviewed 980 patients who underwent radical…”
    Get full text
    Journal Article
  11. 11

    High flow malignant priapism with isolated metastasis to the corpora cavernosa by Dubocq, Francisco M., Tefilli, Marcos V., Grignon, David J., Pontes, J.E., Dhabuwala, C.B.

    Published in Urology (Ridgewood, N.J.) (01-02-1998)
    “…Malignant priapism is a rare disease with only 88 reported cases. We present a case of a patient with priapism secondary to isolated metastasis to corpora…”
    Get full text
    Journal Article
  12. 12

    Predictors For Maximal Outcome in Patients Undergoing Salvage Surgery For Radio-Recurrent Prostate Cancer by Gheiler, Edward L, Tefilli, Marcos V, Tiguert, Rabi, Grignon, David, Cher, Michael L, Sakr, Wael, Pontes, J.Edson, Wood, David P

    Published in Urology (Ridgewood, N.J.) (01-05-1998)
    “…Objectives. To determine preradiation and preoperative clinical staging and postoperative pathologic factors that can predict disease-free survival in patients…”
    Get full text
    Journal Article
  13. 13

    Management of primary urethral cancer by Gheiler, Edward L, Tefilli, Marcos V, Tiguert, Rabi, de Oliveira, J.Gomes, Pontes, J.Edson, Wood, David P

    Published in Urology (Ridgewood, N.J.) (01-09-1998)
    “…Objectives. To determine the best therapeutic approach for treatment of patients with urethral cancer according to tumor location and clinical-pathologic…”
    Get full text
    Journal Article
  14. 14

    Allelic loss in locally metastatic, multisampled prostate cancer by SAKR, W. A, MACOSKA, J. A, BENSON, P, GRIGNON, D. J, WOLMAN, S. R, PONTES, J. E, CRISSMAN, J. D

    Published in Cancer research (Chicago, Ill.) (15-06-1994)
    “…In order to determine whether retention or loss of potential tumor suppressor loci that map to 8p, 10q, or 16q reflect genetic relationships among prostatic…”
    Get full text
    Journal Article
  15. 15

    Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer by Tefilli, M V, Gheiler, E L, Tiguert, R, Banerjee, M, Sakr, W, Grignon, D J, Pontes, J E, Wood, Jr, D P

    Published in The Journal of urology (01-09-1998)
    “…We identify prognostic factors in patients with seminal vesicle involvement and negative lymph nodes following radical prostatectomy for clinically localized…”
    Get more information
    Journal Article
  16. 16

    Should Gleason score 7 prostate cancer be considered a unique grade category? by Tefilli, Marcos V, Gheiler, Edward L, Tiguert, Rabi, Sakr, Wael, Grignon, David J, Banerjee, Mousumi, Pontes, J.Edson, Wood, David P

    Published in Urology (Ridgewood, N.J.) (01-02-1999)
    “…Objectives. To evaluate pathologic characteristics and biochemical survival rate differences between patients with Gleason score 6 or less, 7, and 8 or more…”
    Get full text
    Journal Article
  17. 17

    Prognostic implications of a positive apical margin in radical prostatectomy specimens by Fesseha, T, Sakr, W, Grignon, D, Banerjee, M, Wood, Jr, D P, Pontes, J E

    Published in The Journal of urology (01-12-1997)
    “…We evaluated the prognostic implication of a positive surgical margin at the prostatic apex to define the risk of failure after radical prostatectomy. Radical…”
    Get more information
    Journal Article
  18. 18

    Results of a clinical care pathway for radical prostatectomy patients in an open hospital - multiphysician system by Gheiler, E L, Lovisolo, J A, Tiguert, R, Tefilli, M V, Grayson, T, Oldford, G, Powell, I J, Famiglietti, G, Banerjee, M, Pontes, J E, Wood, Jr, D P

    Published in European urology (1999)
    “…The object of this study was to evaluate the results of a comprehensive clinical care pathway (CCP) aimed at reducing the length of hospitalization and overall…”
    Get more information
    Journal Article
  19. 19

    Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer by MACOSKA, J. A, TRYBUS, T. M, SAKR, W. A, WOLF, M. C, BENSON, P. D, POWELL, I. J, PONTES, J. E

    Published in Cancer research (Chicago, Ill.) (15-07-1994)
    “…Cytogenetic and molecular biological studies have demonstrated deletion of sequences that map to the short arm of chromosome 8 (8p) in tumors from several…”
    Get full text
    Journal Article
  20. 20

    Salvage surgery for radiation failure in prostate cancer by Pontes, J E, Montie, J, Klein, E, Huben, R

    Published in Cancer (01-02-1993)
    “…Salvage surgery was done in 43 patients who did not respond to radiation therapy of prostate cancer between 1982-1991. Thirty-five patients underwent salvage…”
    Get more information
    Journal Article